?. Yal??N
AuthID: R-00J-ZA1
1
TÃTULO: Overall survival results from a phase III trial of trifluridine/tipiracil (FTD/TPI) vs placebo in patients (Pts) with metastatic gastric cancer refractory to standard therapies (TAGS)
AUTORES: Shitara, K; Tabernero, J; Dvorkin, M; Mansoor, W; Arkenau, HT; Prokharau, A; Alsina, M; Ghidini, M; Faustino, C; Gorbunova, V; Zhavrid, E; Nishikawa, K; Hosokawa, A; Ganea, D; Yalçın, Ş; Fujitani, K; Beretta, G; Winkler, R; Doi, T; Ilson, DH;
PUBLICAÇÃO: 2018, FONTE: Annals of Oncology, VOLUME: 29
AUTORES: Shitara, K; Tabernero, J; Dvorkin, M; Mansoor, W; Arkenau, HT; Prokharau, A; Alsina, M; Ghidini, M; Faustino, C; Gorbunova, V; Zhavrid, E; Nishikawa, K; Hosokawa, A; Ganea, D; Yalçın, Ş; Fujitani, K; Beretta, G; Winkler, R; Doi, T; Ilson, DH;
PUBLICAÇÃO: 2018, FONTE: Annals of Oncology, VOLUME: 29
INDEXADO EM: 
Scopus
Scopus